Loading…
Forecasting demand for Hib-containing vaccine in the world's poorest countries: A 4-year prospective experience
Abstract This article analyzes the performance of a Hib vaccine demand forecast developed in 2003 for 68 GAVI-supported countries between 2004 and 2007. During that period of time, corresponding to an acceleration of Hib vaccine uptake, several groups of countries were identified based on the stage...
Saved in:
| Published in: | Vaccine 2009-01, Vol.27 (3), p.410-415 |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c538t-efb59935d010073f40391e62b53cd2d7d16225ea13547c7fcb6cb1521b3b159c3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c538t-efb59935d010073f40391e62b53cd2d7d16225ea13547c7fcb6cb1521b3b159c3 |
| container_end_page | 415 |
| container_issue | 3 |
| container_start_page | 410 |
| container_title | Vaccine |
| container_volume | 27 |
| creator | Zuber, Patrick L.F Dumolard, Laure Shirey, Meredith Rizzo, Ivone Marshall, John |
| description | Abstract This article analyzes the performance of a Hib vaccine demand forecast developed in 2003 for 68 GAVI-supported countries between 2004 and 2007. During that period of time, corresponding to an acceleration of Hib vaccine uptake, several groups of countries were identified based on the stage of their decision-making process, perception of Hib disease burden and programme performance. Better forecast accuracy was obtained for countries having already introduced the vaccine or that were about to do so. The ability to anticipate global needs in terms of vaccine volumes was highly dependant on the actual year of introduction of a small number of very large countries. |
| doi_str_mv | 10.1016/j.vaccine.2008.10.069 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66747504</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X0801493X</els_id><sourcerecordid>66747504</sourcerecordid><originalsourceid>FETCH-LOGICAL-c538t-efb59935d010073f40391e62b53cd2d7d16225ea13547c7fcb6cb1521b3b159c3</originalsourceid><addsrcrecordid>eNqFkk1v1DAQhiMEokvhJ4AsIcopy4wd54MDqKooRarEAZB6sxxnAl6y9tbObtl_j8NGVOplTyN5npl5Pe9k2UuEJQKW71bLnTbGOlpygDq9LaFsHmULrCuRc4n142wBvCzyAuHmJHsW4woApMDmaXaCDaAoGrHI_KUPZHQcrfvJOlpr17HeB3Zl29x4N2rrpsw8i1nHxl_E7nwYureRbXyqjiMzfuvGYCm-Z-esyPekA9sEHzdkRrsjRn82lNLO0PPsSa-HSC_meJr9uPz0_eIqv_76-cvF-XVupKjHnPpWNo2QHSBAJfoCRINU8lYK0_Gu6rDkXJJGIYvKVL1pS9Oi5NiKFBojTrOzQ98k43abNKq1jYaGQTvy26jKsioqCcVRkE-ToZZHQWwkJhgS-PoBuPLb4NJvFRYNSJkEYqLkgTJpTzFQrzbBrnXYKwQ1OaxWat66mhyenpPDqe7V3H3brqm7r5otTcCbGdDR6KEP2hkb_3McoeK8mGR-PHCUbNhZCiqafxZ1Nl3EqDpvj0r58KCDGdK5pKG_aU_x_tcqcgXq23SO0zVCDWkR4kb8BXOD2sA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1490551591</pqid></control><display><type>article</type><title>Forecasting demand for Hib-containing vaccine in the world's poorest countries: A 4-year prospective experience</title><source>ScienceDirect Journals</source><creator>Zuber, Patrick L.F ; Dumolard, Laure ; Shirey, Meredith ; Rizzo, Ivone ; Marshall, John</creator><creatorcontrib>Zuber, Patrick L.F ; Dumolard, Laure ; Shirey, Meredith ; Rizzo, Ivone ; Marshall, John</creatorcontrib><description>Abstract This article analyzes the performance of a Hib vaccine demand forecast developed in 2003 for 68 GAVI-supported countries between 2004 and 2007. During that period of time, corresponding to an acceleration of Hib vaccine uptake, several groups of countries were identified based on the stage of their decision-making process, perception of Hib disease burden and programme performance. Better forecast accuracy was obtained for countries having already introduced the vaccine or that were about to do so. The ability to anticipate global needs in terms of vaccine volumes was highly dependant on the actual year of introduction of a small number of very large countries.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2008.10.069</identifier><identifier>PMID: 19013493</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Allergy and Immunology ; Applied microbiology ; Bacterial Capsules - immunology ; Bacteriology ; Biological and medical sciences ; Delphi method ; Demand forecast ; Developing Countries ; Estimates ; Forecasting ; Fundamental and applied biological sciences. Psychology ; Funding ; Haemophilus Infections - epidemiology ; Haemophilus Infections - microbiology ; Haemophilus influenzae ; Haemophilus influenzae type b - immunology ; Haemophilus Vaccines - immunology ; Hepatitis B ; Humans ; Immunization ; Microbiology ; Miscellaneous ; Tetanus ; Vaccination - trends ; Vaccination - utilization ; Vaccine ; Vaccines ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) ; Whooping cough</subject><ispartof>Vaccine, 2009-01, Vol.27 (3), p.410-415</ispartof><rights>Elsevier Ltd</rights><rights>2008 Elsevier Ltd</rights><rights>2009 INIST-CNRS</rights><rights>Copyright Elsevier Limited Jan 14, 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c538t-efb59935d010073f40391e62b53cd2d7d16225ea13547c7fcb6cb1521b3b159c3</citedby><cites>FETCH-LOGICAL-c538t-efb59935d010073f40391e62b53cd2d7d16225ea13547c7fcb6cb1521b3b159c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21072240$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19013493$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zuber, Patrick L.F</creatorcontrib><creatorcontrib>Dumolard, Laure</creatorcontrib><creatorcontrib>Shirey, Meredith</creatorcontrib><creatorcontrib>Rizzo, Ivone</creatorcontrib><creatorcontrib>Marshall, John</creatorcontrib><title>Forecasting demand for Hib-containing vaccine in the world's poorest countries: A 4-year prospective experience</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Abstract This article analyzes the performance of a Hib vaccine demand forecast developed in 2003 for 68 GAVI-supported countries between 2004 and 2007. During that period of time, corresponding to an acceleration of Hib vaccine uptake, several groups of countries were identified based on the stage of their decision-making process, perception of Hib disease burden and programme performance. Better forecast accuracy was obtained for countries having already introduced the vaccine or that were about to do so. The ability to anticipate global needs in terms of vaccine volumes was highly dependant on the actual year of introduction of a small number of very large countries.</description><subject>Allergy and Immunology</subject><subject>Applied microbiology</subject><subject>Bacterial Capsules - immunology</subject><subject>Bacteriology</subject><subject>Biological and medical sciences</subject><subject>Delphi method</subject><subject>Demand forecast</subject><subject>Developing Countries</subject><subject>Estimates</subject><subject>Forecasting</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Funding</subject><subject>Haemophilus Infections - epidemiology</subject><subject>Haemophilus Infections - microbiology</subject><subject>Haemophilus influenzae</subject><subject>Haemophilus influenzae type b - immunology</subject><subject>Haemophilus Vaccines - immunology</subject><subject>Hepatitis B</subject><subject>Humans</subject><subject>Immunization</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Tetanus</subject><subject>Vaccination - trends</subject><subject>Vaccination - utilization</subject><subject>Vaccine</subject><subject>Vaccines</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><subject>Whooping cough</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqFkk1v1DAQhiMEokvhJ4AsIcopy4wd54MDqKooRarEAZB6sxxnAl6y9tbObtl_j8NGVOplTyN5npl5Pe9k2UuEJQKW71bLnTbGOlpygDq9LaFsHmULrCuRc4n142wBvCzyAuHmJHsW4woApMDmaXaCDaAoGrHI_KUPZHQcrfvJOlpr17HeB3Zl29x4N2rrpsw8i1nHxl_E7nwYureRbXyqjiMzfuvGYCm-Z-esyPekA9sEHzdkRrsjRn82lNLO0PPsSa-HSC_meJr9uPz0_eIqv_76-cvF-XVupKjHnPpWNo2QHSBAJfoCRINU8lYK0_Gu6rDkXJJGIYvKVL1pS9Oi5NiKFBojTrOzQ98k43abNKq1jYaGQTvy26jKsioqCcVRkE-ToZZHQWwkJhgS-PoBuPLb4NJvFRYNSJkEYqLkgTJpTzFQrzbBrnXYKwQ1OaxWat66mhyenpPDqe7V3H3brqm7r5otTcCbGdDR6KEP2hkb_3McoeK8mGR-PHCUbNhZCiqafxZ1Nl3EqDpvj0r58KCDGdK5pKG_aU_x_tcqcgXq23SO0zVCDWkR4kb8BXOD2sA</recordid><startdate>20090114</startdate><enddate>20090114</enddate><creator>Zuber, Patrick L.F</creator><creator>Dumolard, Laure</creator><creator>Shirey, Meredith</creator><creator>Rizzo, Ivone</creator><creator>Marshall, John</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20090114</creationdate><title>Forecasting demand for Hib-containing vaccine in the world's poorest countries: A 4-year prospective experience</title><author>Zuber, Patrick L.F ; Dumolard, Laure ; Shirey, Meredith ; Rizzo, Ivone ; Marshall, John</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c538t-efb59935d010073f40391e62b53cd2d7d16225ea13547c7fcb6cb1521b3b159c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Allergy and Immunology</topic><topic>Applied microbiology</topic><topic>Bacterial Capsules - immunology</topic><topic>Bacteriology</topic><topic>Biological and medical sciences</topic><topic>Delphi method</topic><topic>Demand forecast</topic><topic>Developing Countries</topic><topic>Estimates</topic><topic>Forecasting</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Funding</topic><topic>Haemophilus Infections - epidemiology</topic><topic>Haemophilus Infections - microbiology</topic><topic>Haemophilus influenzae</topic><topic>Haemophilus influenzae type b - immunology</topic><topic>Haemophilus Vaccines - immunology</topic><topic>Hepatitis B</topic><topic>Humans</topic><topic>Immunization</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Tetanus</topic><topic>Vaccination - trends</topic><topic>Vaccination - utilization</topic><topic>Vaccine</topic><topic>Vaccines</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</topic><topic>Whooping cough</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zuber, Patrick L.F</creatorcontrib><creatorcontrib>Dumolard, Laure</creatorcontrib><creatorcontrib>Shirey, Meredith</creatorcontrib><creatorcontrib>Rizzo, Ivone</creatorcontrib><creatorcontrib>Marshall, John</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>ProQuest Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest Health Management</collection><collection>Medical Database</collection><collection>ProQuest Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zuber, Patrick L.F</au><au>Dumolard, Laure</au><au>Shirey, Meredith</au><au>Rizzo, Ivone</au><au>Marshall, John</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Forecasting demand for Hib-containing vaccine in the world's poorest countries: A 4-year prospective experience</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2009-01-14</date><risdate>2009</risdate><volume>27</volume><issue>3</issue><spage>410</spage><epage>415</epage><pages>410-415</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>Abstract This article analyzes the performance of a Hib vaccine demand forecast developed in 2003 for 68 GAVI-supported countries between 2004 and 2007. During that period of time, corresponding to an acceleration of Hib vaccine uptake, several groups of countries were identified based on the stage of their decision-making process, perception of Hib disease burden and programme performance. Better forecast accuracy was obtained for countries having already introduced the vaccine or that were about to do so. The ability to anticipate global needs in terms of vaccine volumes was highly dependant on the actual year of introduction of a small number of very large countries.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>19013493</pmid><doi>10.1016/j.vaccine.2008.10.069</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2009-01, Vol.27 (3), p.410-415 |
| issn | 0264-410X 1873-2518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_66747504 |
| source | ScienceDirect Journals |
| subjects | Allergy and Immunology Applied microbiology Bacterial Capsules - immunology Bacteriology Biological and medical sciences Delphi method Demand forecast Developing Countries Estimates Forecasting Fundamental and applied biological sciences. Psychology Funding Haemophilus Infections - epidemiology Haemophilus Infections - microbiology Haemophilus influenzae Haemophilus influenzae type b - immunology Haemophilus Vaccines - immunology Hepatitis B Humans Immunization Microbiology Miscellaneous Tetanus Vaccination - trends Vaccination - utilization Vaccine Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) Whooping cough |
| title | Forecasting demand for Hib-containing vaccine in the world's poorest countries: A 4-year prospective experience |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T01%3A18%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Forecasting%20demand%20for%20Hib-containing%20vaccine%20in%20the%20world's%20poorest%20countries:%20A%204-year%20prospective%20experience&rft.jtitle=Vaccine&rft.au=Zuber,%20Patrick%20L.F&rft.date=2009-01-14&rft.volume=27&rft.issue=3&rft.spage=410&rft.epage=415&rft.pages=410-415&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/j.vaccine.2008.10.069&rft_dat=%3Cproquest_cross%3E66747504%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c538t-efb59935d010073f40391e62b53cd2d7d16225ea13547c7fcb6cb1521b3b159c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1490551591&rft_id=info:pmid/19013493&rfr_iscdi=true |